Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter. (Q48486475)

11 February 2018

title

Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter. (English)

1 reference

11 February 2018

1 reference

P Valensi

1

1 reference

11 February 2018

S Chiheb

series ordinal

2

1 reference

11 February 2018

M Fysekidis

series ordinal

3

1 reference

11 February 2018

publication date

13 April 2013

1 reference

11 February 2018

published in

Diabetologia

1 reference

11 February 2018

volume

56

1 reference

11 February 2018

page(s)

1196-1200

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-013-2909-x

exact match

0 references

cites work

The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

An overview of the effect of weight loss on cardiovascular autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

The effect of insulin on cardiac autonomic balance predicts weight reduction after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Influence of nutrients on cardiac autonomic function in nondiabetic overweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: influence of rheological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Distribution of GLP-1 and PACAP receptors in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

C-peptide: new findings and therapeutic implications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2909-X

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

21 January 2018

1 reference

12 December 2020

Low cerebrospinal fluid insulin levels in obese humans

1 reference

12 December 2020

Acute effect of insulin on autonomic regulation of the cardiovascular system: a study by heart rate spectral analysis

1 reference

12 December 2020

Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats

1 reference

12 December 2020

Adrenergic and reflex abnormalities in obesity-related hypertension

1 reference

12 December 2020

Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects

1 reference

12 December 2020

Insulin stimulates epinephrine release under euglycemic conditions in humans

1 reference

12 December 2020

Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs

1 reference

12 December 2020

Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control

1 reference

12 December 2020

Resting heart rate in middle age and diabetes development in older age

1 reference

12 December 2020

Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states.

1 reference

12 December 2020

Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects.

1 reference

12 December 2020

[Dynamic monitoring of blood pressure and assessment of antihypertensive drugs]

1 reference

12 December 2020

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

12 December 2020

Cardiac autonomic function in obese patients

1 reference

12 December 2020

Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats.

1 reference

12 December 2020

10.1007/S00125-013-2909-X

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

23584434

1 reference

11 February 2018